Norden Group »

Supernus Pharmaceuticals shares owned by Norden Group

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Norden Group from 13F filings

Historical chart of Norden Group investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Norden Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Norden Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $292k 8.6k 34.11

More positions owned by Norden Group

Microsoft Corporation (MSFT)
Amazon (AMZN)
Pgim Etf Tr Pgim Ultra Sh Bd (PULS)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Apple (AAPL)
Spdr Ser Tr Bloomberg High Y (JNK)
NVIDIA Corporation (NVDA)
Ishares Tr U.s. Finls Etf (IYF)
Ishares Tr Us Industrials (IYJ)
Ishares Tr Us Consum Discre (IYC)
Ishares Tr U.s. Tech Etf (IYW)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Netflix (NFLX)

View all positions for Norden Group

Top funds holding Supernus Pharmaceuticals

Vanguard Group
Dimensional Fund Advisors
Jennifer Ranahan
Congress Asset Management
Ashford Capital Management
Victory Capital Management
Charles Schwab Investment Management
Rice Hall James & Associates
T. Rowe Price Associates
Bank of New York Mellon
Bank of America Corporation
Tributary Capital Management
Mutual Of America Capital Management
Principal Financial Group
Norges Bank Investment Management

View all funds holding Supernus Pharmaceuticals